Evidence map›Paper›PMID 38903927›Full record

ArticleInternational journal of medical sciences2024

Analysis of prognostic biomarker models of TXNIP/NLRP3/IL1B inflammasome pathway in patients with acute myeloid leukemia.

Junjie Chen, Qi Hou, Tao Chang, Jiamian Zheng, Chao Yao, Junyi He, Shengting Chen, Xiuli Wu, Zhenyi Jin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of medical sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Junjie ChenThe First Affiliated Hospital and Institute of Hematology, School of Medicine, Jinan University, Guangzhou, China.
Qi HouThe First Affiliated Hospital and Institute of Hematology, School of Medicine, Jinan University, Guangzhou, China.
Tao ChangDepartment of Biochemistry, School of Medicine, Jinan University, Guangzhou, China.
Jiamian ZhengThe First Affiliated Hospital and Institute of Hematology, School of Medicine, Jinan University, Guangzhou, China.
Chao YaoThe First Affiliated Hospital and Institute of Hematology, School of Medicine, Jinan University, Guangzhou, China.
Junyi HeThe First Affiliated Hospital and Institute of Hematology, School of Medicine, Jinan University, Guangzhou, China.
Shengting ChenDepartment of Blood Transfusion, The First Affiliated Hospital, Jinan University, Guangzhou, China.
Xiuli WuThe First Affiliated Hospital and Institute of Hematology, School of Medicine, Jinan University, Guangzhou, China.
Zhenyi JinSchool of Medicine, Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biomarkers, TumorCarrier ProteinsInflammasomesInterleukin-1betaLeukemia, Myeloid, AcuteNLR Family, Pyrin Domain-Containing 3 ProteinAdultAgedFemaleGene Expression Regulation, LeukemicHumansMaleMiddle AgedPrognosisSignal TransductionThioredoxinsBiomarkers, TumorCarrier ProteinsIL1B protein, humanInflammasomesInterleukin-1betaNLR Family, Pyrin Domain-Containing 3 ProteinNLRP3 protein, humanThioredoxinsTXNIP protein, humanAcute myeloid leukemiabiomarkerNLRP3prognosisTXNIP

Identifiers

PMID38903927
PMCPMC11186430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.